Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Verbeek

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Neuroradiology|September 10, 2005
Meningoencephalitis caused by Streptococcus pneumoniae: a diagnostic and therapeutic challenge. Diagnosis with diffusion-weighted MRI leading to treatment with corticosteroidsPhilippe G Jorens, Paul M Parizel, Hendrik E Demey, et al.
Acta Neurochirurgica|January 25, 2003
Serum- and CSF-concentrations of brain specific proteins in hydrocephalusT Beems, K S Simons, W J A Van Geel, et al.
Neuropathology and Applied Neurobiology|June 4, 2004
Differential gene expression in human brain pericytes induced by amyloid-beta proteinA A M Rensink, I Otte-Höller, H J ten Donkelaar, et al.
Brain Research Bulletin|August 12, 2003
Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patientsK J B Lamers, P Vos, M M Verbeek, et al.
The American Journal of Pathology|December 14, 1999
Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brainM M Verbeek, I Otte-Höller, J van den Born, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 19, 2009
CSF biomarker utilisation and ethical considerations of biomarker assisted diagnosis and research in dementia: perspectives from within the European Alzheimer's Disease Consortium (EADC)D Slats, P E Spies, M J C Sjögren, et al.
Neurology|January 13, 2006
Prediction of poor outcome within the first 3 days of postanoxic comaE G J Zandbergen, A Hijdra, J H T M Koelman, et al.
Current Alzheimer Research|January 2, 2010
The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementiaP E Spies, D Slats, J M C Sjögren, et al.
Acta Neuropathologica|January 5, 2002
Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brainsJ van Horssen, I Otte-Höller, G David, et al.
AJNR. American Journal of Neuroradiology|October 24, 2014
Susceptibility-weighted imaging improves the diagnostic accuracy of 3T brain MRI in the work-up of parkinsonismF J A Meijer, A van Rumund, B A C M Fasen, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Neuroradiology|September 10, 2005
Meningoencephalitis caused by Streptococcus pneumoniae: a diagnostic and therapeutic challenge. Diagnosis with diffusion-weighted MRI leading to treatment with corticosteroidsPhilippe G Jorens, Paul M Parizel, Hendrik E Demey, et al.
Acta Neurochirurgica|January 25, 2003
Serum- and CSF-concentrations of brain specific proteins in hydrocephalusT Beems, K S Simons, W J A Van Geel, et al.
Neuropathology and Applied Neurobiology|June 4, 2004
Differential gene expression in human brain pericytes induced by amyloid-beta proteinA A M Rensink, I Otte-Höller, H J ten Donkelaar, et al.
Brain Research Bulletin|August 12, 2003
Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patientsK J B Lamers, P Vos, M M Verbeek, et al.
The American Journal of Pathology|December 14, 1999
Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brainM M Verbeek, I Otte-Höller, J van den Born, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 19, 2009
CSF biomarker utilisation and ethical considerations of biomarker assisted diagnosis and research in dementia: perspectives from within the European Alzheimer's Disease Consortium (EADC)D Slats, P E Spies, M J C Sjögren, et al.
Neurology|January 13, 2006
Prediction of poor outcome within the first 3 days of postanoxic comaE G J Zandbergen, A Hijdra, J H T M Koelman, et al.
Current Alzheimer Research|January 2, 2010
The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementiaP E Spies, D Slats, J M C Sjögren, et al.
Acta Neuropathologica|January 5, 2002
Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brainsJ van Horssen, I Otte-Höller, G David, et al.
AJNR. American Journal of Neuroradiology|October 24, 2014
Susceptibility-weighted imaging improves the diagnostic accuracy of 3T brain MRI in the work-up of parkinsonismF J A Meijer, A van Rumund, B A C M Fasen, et al.
Pageof 8